Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) begins acting in your body from the first injection, but most people notice meaningful appetite changes between weeks four and eight, and significant weight loss typically builds over several months of treatment. The timeline varies by dose and individual, and Wegovy is a prescription-only medicine requiring clinical assessment before use. Here is what the evidence actually shows, stripped of the most common misunderstanding about when this medicine starts to "work".
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
People often assume Wegovy is not working because the scales barely move in the first month. That framing gets the mechanism back to front. Semaglutide is a GLP-1 receptor agonist, it slows gastric emptying and reduces appetite signals to the brain. Those effects begin after your first injection, but the starting dose of 0.25mg is there to let your body adjust, not to produce visible fat loss straight away. The titration process (moving from 0.25mg through 0.5mg, 1mg, 1.7mg, and eventually to 2.4mg over roughly 16–20 weeks) is building towards therapeutic effect while keeping side effects manageable. Expecting the scales to move dramatically at 0.25mg is like expecting a car to reach motorway speed in first gear. The NHS's patient information on semaglutide explains the dose schedule in plain terms and is worth reading before your first pen.
Most people do notice reduced hunger and earlier fullness within the first two to four weeks, even at the starter dose, and if you want to understand how long after your Wegovy shot it starts to work, that page breaks down what to expect in the hours and days following each injection. That is the medicine working. The weight loss comes as a downstream result of sustained calorie reduction over months.
The STEP 1 trial, published in the New England Journal of Medicine, followed adults with obesity over 68 weeks. At the 2.4mg maintenance dose, participants lost around 15% of body weight on average. The rate of loss was not uniform: it was steepest in the first 20 weeks as doses increased, then continued more gradually through the remainder of the treatment period. Weight loss was still progressing at week 68 for many participants. If you are curious how the Wegovy weight-loss timeline breaks down across those months, a fuller look at the data is available. The 7.2mg pen (approved by the MHRA in April 2026) showed around 20.7% average weight loss in its pivotal trials over 72 weeks, narrowing the gap with tirzepatide. NICE's appraisal of semaglutide provides the threshold that matters practically: less than 5% weight loss after six months at the maintenance dose is the clinical signal to reassess.
The short version: weeks one to four are about tolerance and appetite changes; months two to six are where most measurable loss accumulates; and months six to eighteen can see continued progress. A realistic personal target is set in consultation with your prescriber, not by the average trial figure.
Several factors shift the timeline for individuals. Dose level matters enormously: someone on 1mg will see less loss than someone on 2.4mg, all else equal. Diet composition still plays a role, Wegovy reduces hunger but does not eliminate it, and protein intake and fibre help protect muscle mass and sustain the effect. Activity levels make a measurable difference to body composition even if not always to the number on the scale. Some people experience a plateau after significant early loss, which is a normal physiological response and not a sign the medicine has stopped working.
On the practical side, injection timing matters less than consistency. Most people pick a day that fits their routine and stick to it, some keep their pen in the fridge door and set a weekly phone reminder tied to the same day they collect the post. If you miss a dose by more than a few days, your Patient Information Leaflet and prescriber are the right guides on what to do next.
Side effects, primarily nausea and digestive discomfort, are most noticeable during dose increases and usually settle within one to two weeks at each new level. They can temporarily suppress appetite beyond what is comfortable, which is one reason that eating smaller, lower-fat meals during titration is widely recommended. For more detail on the full Wegovy treatment overview, including the side-effect profile and eligibility criteria, that page covers the medicine comprehensively.
The honest answer to "how long until it works" is that it depends on which outcome you mean. Appetite reduction: within days to weeks. Noticeable weight change: one to three months. Clinically significant loss: typically three to six months and beyond, and if you want a clear picture of how long Wegovy treatment typically runs and what the overall duration looks like, that page covers it in full.
Wegovy is a prescription-only medicine, so any decision about starting, continuing, or adjusting it sits with a prescriber. Private treatment costs are worth understanding before you commit, our guide to Wegovy costs in the UK sets out what private pricing typically includes and what to ask about. And if you want to understand how early signs that Wegovy is starting to work feel in practice, that page goes into appetite signals in more detail.
At nume, a real prescriber reviews your consultation the same day, not software, not an automated queue. If Wegovy is the right fit clinically, treatment is dispatched the same day with free next-working-day delivery. There are no subscriptions, no automatic renewals, and every repeat order is reviewed again before it goes out. If you are ready to understand your options properly, start your free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.